Author: P. Sadeghipour, MD
-
Daily Cardiology Symposium 1403: Cardiovascular Risk Modifiers
July 17, 2024DCS 1403: CVD Risk Modifiers
-
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis
November 27, 2023Case Discussion 98 Answer: Anticoagulation after cerebral venous sinus thrombosis
-
-
-
-
Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases
June 26, 2022DCS 1401: Peripheral vascular diseases
-
which prophylaxis? for whom? VTE prophylaxis panel discussion
January 26, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: which prophylaxis? for whom? VTE prophylaxis panel discussion
January 19, 2022Case-based panel discussion on VTE prophylaxis
-
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
January 2, 2022Umbrella H&S: session 2, carotid stenosis
-
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Save the date: VTE Prophylaxis in Patients with COVID-19
October 20, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
VTE Prophylaxis in Patients with COVID-19
October 19, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial
August 27, 2020Monthly Case-Based Clinical Problem Solving
-
-
-
Low-dose Rivaroxaban in Management of PAD Patients
June 23, 2020Insights from COMPASS & VOYAGER Trials
-
-
Case Discussion (5)
May 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Antithrombotic Therapy in CCS
-
-
